highly significantp < 0.001
The MTX‐treated group, as expected, demonstrated a highly significant reduction in paw edema, from 7.36 ± 0.35 to 3.54 ± 0.04 mL, which corresponds to a 51% reduction ( p < 0.001), confirming its effectiveness as a standard anti‐inflammatory drug.